CSLLY
Price
$57.79
Change
-$0.98 (-1.67%)
Updated
Jan 13 closing price
Capitalization
56.4B
Intraday BUY SELL Signals
RXRX
Price
$4.85
Change
+$0.16 (+3.41%)
Updated
Jan 14 closing price
Capitalization
2.52B
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CSLLY vs RXRX

Header iconCSLLY vs RXRX Comparison
Open Charts CSLLY vs RXRXBanner chart's image
CSL
Price$57.79
Change-$0.98 (-1.67%)
Volume$132.3K
Capitalization56.4B
Recursion Pharmaceuticals
Price$4.85
Change+$0.16 (+3.41%)
Volume$16.95M
Capitalization2.52B
CSLLY vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
CSLLY vs. RXRX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSLLY is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CSLLY: $58.30 vs. RXRX: $4.85)
Brand notoriety: CSLLY and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSLLY: 62% vs. RXRX: 73%
Market capitalization -- CSLLY: $56.25B vs. RXRX: $2.52B
CSLLY [@Biotechnology] is valued at $56.25B. RXRX’s [@Biotechnology] market capitalization is $2.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSLLY’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • CSLLY’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than CSLLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSLLY’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • CSLLY’s TA Score: 3 bullish, 5 bearish.
  • RXRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than CSLLY.

Price Growth

CSLLY (@Biotechnology) experienced а +1.69% price change this week, while RXRX (@Biotechnology) price change was -0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

RXRX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSLLY($56.4B) has a higher market cap than RXRX($2.52B). RXRX YTD gains are higher at: 18.582 vs. CSLLY (0.330). CSLLY has higher annual earnings (EBITDA): 5.13B vs. RXRX (-636.09M). CSLLY has more cash in the bank: 1.52B vs. RXRX (660M). RXRX has less debt than CSLLY: RXRX (82.4M) vs CSLLY (12B). CSLLY has higher revenues than RXRX: CSLLY (15.4B) vs RXRX (43.4M).
CSLLYRXRXCSLLY / RXRX
Capitalization56.4B2.52B2,235%
EBITDA5.13B-636.09M-807%
Gain YTD0.33018.5822%
P/E Ratio18.73N/A-
Revenue15.4B43.4M35,484%
Total Cash1.52B660M231%
Total Debt12B82.4M14,563%
FUNDAMENTALS RATINGS
CSLLY: Fundamental Ratings
CSLLY
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSLLYRXRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
51%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
53%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 13 days ago
67%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CSLLY
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ODMCX10.040.06
+0.60%
JPMorgan SMID Cap Equity C
EISIX33.120.06
+0.18%
Carillon ClariVest Intl Stock I
RMOMX25.32-0.09
-0.35%
Victory RS Mid Cap Growth Member
MSALX25.70-0.17
-0.66%
Morgan Stanley Inst Intl Advtg L
FGSRX133.99-0.96
-0.71%
Franklin Growth R

CSLLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSLLY has been loosely correlated with ADPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CSLLY jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSLLY
1D Price
Change %
CSLLY100%
-1.67%
ADPT - CSLLY
34%
Loosely correlated
-1.04%
RXRX - CSLLY
34%
Loosely correlated
-2.49%
VIR - CSLLY
33%
Poorly correlated
+6.59%
FOLD - CSLLY
33%
Poorly correlated
+0.28%
CDXS - CSLLY
33%
Poorly correlated
+1.79%
More